News - Production, Daiichi Sankyo


Current filters:

ProductionDaiichi Sankyo

Popular Filters

Ranbaxy temporarily suspends shipments from Toansa and Dewas plants


Indian drugmaker Ranbaxy Laboratories has announced in a letter to the Stock Exchange that it has temporarily…

Asia-PacificDaiichi SankyoGenericsIndiaProductionRanbaxy Laboratories

Another ban by US FDA on a Ranbaxy production facility

Another ban by US FDA on a Ranbaxy production facility


As if the Indian drug major has not had enough negative news from the US regulator, the US Food and Drug…

Asia-PacificDaiichi SankyoGenericsIndiaNorth AmericaProductionRanbaxy LaboratoriesRegulationUSA

Ban on FDA-regulated drugs from Ranbaxy's Mohali plant


There was another blow for India's largest drugmaker Ranbaxy Laboratories (BSE: 500359) yesterday (September…

Asia-PacificDaiichi SankyoGenericsNorth AmericaProductionRanbaxy LaboratoriesRegulation

Germany's Saltigo to manufacture novel drug pipeline product for Daiichi Sankyo


German custom manufacturing specialist Saltigo GmbH, a subsidiary of Lanxess (Xetra: LXS), has signed…

Daiichi SankyoLanxessPharmaceuticalProductionSaltigo GmbH

Ranbaxy highlights its actions on improved business and quality assurance


Indian drugmaker Ranbaxy Laboratories (BSE: 500359), whose US subsidiary was the subject of the biggest…

Daiichi SankyoGenericsManagementProductionRanbaxy LaboratoriesRegulation

US DoJ says Ranbaxy pleads guilty and agrees to pay $500 million in settlements


In the largest drug safety settlement to date with a generic drug manufacturer, Ranbaxy USA, a subsidiary…

Asia-PacificDaiichi SankyoFinancialGenericsLegalNorth AmericaProductionRanbaxy LaboratoriesRegulation

Japan briefs: Daiichi Sankyo launches silodosin in China; Fujifilm Diosynth UK unit commissioned


Japanese drug major Daiichi Sankyo says that its subsidiary, Daiichi Sankyo Pharmaceutical (Beijing),…

Asia-PacificBiotechnologyDaiichi SankyoEuropeFujifilm Diosynth BiotechnologiesMarkets & MarketingPharmaceuticalProductionsilodosinUrief

Ranbaxy gains approval for new manufacturing plant in Malaysia


India's largest drugmaker Ranbaxy Laboratories (AB: BO). said yesterday that the government of Malaysia…

Asia-PacificDaiichi SankyoGenericsProductionRanbaxy Laboratories

Back to top